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Conclusions. These studies demonstrate that the calcio-Mechanisms of the regulation of EGF receptor gene expression
tropic hormones PTH and calcitriol increase EGF receptorby calcitriol and parathyroid hormone in UMR 106-01 cells.
expression by different mechanisms. The former increasesBackground. We have previously demonstrated that parathy-
EGFR gene transcription whereas the latter increases EGFRroid hormone (PTH) and calcitriol increase the expression of
mRNA stability.epidermal growth factor receptors (EGFR) in UMR 106-01
osteoblast-like cells. The effect of PTH is mediated by cAMP
and it involves an increase in the level of EGFR mRNA. The
present studies were designed to investigate the mechanisms Epidermal growth factor (EGF) has been shown to
involved in the regulation of EGFR expression by PTH and have several effects in osteoblastic cells including in-
calcitriol. creased proliferation [1, 2], decreased alkaline phospha-
Methods. To examine the mechanism of the effect of calcit- tase and collagen production [3–5], and decreased or in-riol on EGFR expression, confluent cultures of UMR 106-01
creased mineralized nodule formation depending on thecells were exposed to calcitriol and levels of EGFR mRNA
duration of exposure [6]. The finding of EGF transcriptswere determined by reverse transcription-polymerase chain
reaction (RT-PCR). In order to study the effect of calcitriol in osteoblast-like cells suggests a potential role of EGF on
on EGFR gene transcription, a candidate vitamin D-responsive the local regulation of bone remodeling [7]. EGF exerts its
element (VDRE) was identified in the EGFR gene promoter actions via a specific receptor, the EGF receptor (EGFR),
and complimentary 30-mer oligonucleotides spanning this re- a 170-kD transmembrane glycoprotein that has intrinsicgion were tested for binding to recombinant VDR using
tyrosine protein kinase activity [8]. The EGFR has beenEMSA. Transcriptional activity in response to calcitriol and
demonstrated to be present in a variety of cells of the os-PTH was tested in UMR 106-01 cells stably transfected with
teoblastic lineage, including UMR-106-01 cells. The ex-a luciferase reporter construct containing the full length EGFR
gene promoter. The effect of calcitriol on EGFR mRNA stabil- act role of the EGFR in osteoblast biology is not clear,
ity was examined in transcriptionally arrested cells. but evidence suggests that it may be involved in osteoge-
Results. Treatment with calcitriol resulted in a time and dose nic cell differentiation [9], especially since signaling via
dependent increase in EGFR mRNA levels in confluent cul- the EGFR has been shown to oppose BMP signaling, atures of UMR 106-01 osteoblast-like cells. Using EMSA, we
major determinant of the osteoblastic phenotype [10].demonstrated that the putative human EGFR VDRE binds to
The calciotropic hormones parathyroid hormone (PTH)recombinant VDR in a retinoid X receptor (RXR)-dependent
and calcitriol play important roles in osteoblastic devel-manner; however, calcitriol failed to increase transcriptional
activity from a luciferase reporter construct containing the full- opment and activity, and we have previously shown that
length EGFR gene promoter in stably transfected UMR 106-01 PTH increases EGFR binding in UMR 106-01 cells via
cells. Therefore, EGFR mRNA degradation was examined in a cAMP-dependent mechanism [11]. The PTH induced
transcriptionally arrested cells and calcitriol was found to pro- increase in EGFR binding was associated with an in-
long the half life of EGFR mRNA. Treatment of the cultures
crease in the levels of EGFR mRNA [11]. In addition,with PTH resulted in a ninefold increase in luciferase activity
we have found that calcitriol increases EGFR bindingafter four hours of exposure, a finding that was reproduced by
in this cell line [12]. The present studies were designedtreatment with forskolin.
to further investigate the mechanisms involved in the
regulation of EGFR expression by calcitriol and PTH.
Key words: epidermal growth factor receptor, calciotropic hormones,
PTH, osteoblast, gene transcription, vitamin D.
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Dr. Adriana Dusso (Washington University, St. Louis, DNA-Free (Ambion, Austin, TX, USA). The manufac-
turer’s protocol was modified with a one-hour incubationMO, USA), [-32P]dCTP was purchased from Amer-
sham, Life Science (Arlington Heights, IL, USA). All at 37C instead of a 20- to 30-minute incubation to make
sure no DNA was present. The supernatant contain-other reagents were purchased from Sigma-Aldrich Com-
pany (St. Louis, MO, USA) and were of the highest ing the RNA was transferred to a clean PCR tube. The
samples were stored at 70C until used. The concen-grade available.
tration of the RNA preparation was quantitated by
Cell culture absorbance at 260 nm. EGFR mRNA levels were deter-
mined using the one tube Access RT-PCR System (Pro-UMR 106-01 osteoblast-like cells were provided by
Dr. Nicola Partridge (Robert Woods Johnson Medical mega, Madison, WI, USA). Total RNA (0.1 g) was
added to a reverse transcription (RT) mixture containingSchool, Piscataway, NJ, USA). Experiments using UMR
106-01 osteoblast-like cells were performed between pas- 1  AMV/Tfl Reaction Buffer, 0.2 mmol/L dNTP mix,
1 mmol/L MgSO4, 0.1 U/L AMV reverse transcriptase,sages 13 and 23. Cells were grown in Minimum Essential
Medium (MEM) supplemented with 5% serum, penicil- 0.1 U/L Tfl DNA polymerase and 0.5 mol/L of each
EGFR primer in a total volume of 50L. The oligonucleo-lin and streptomycin. Test agents were added to the cells
after they had reached confluency in order to minimize tide primers were synthesized by Gibco. The EGFR for-
ward primer (5-GAGAGGAGAACTGCCAGAA-3)effects on growth.
contained residues 761-779 of the EGFR gene and the
Electromobility shift assay reverse primer (5-GTAGCATTTATGGAGAGTG-3)
contained residues 1196-1214. The thermal cycler pro-Electromobility shift assay (EMSA) was performed
as previously described [13]. Two synthetic oligonucleo- gram was 48C for 45 minutes for RT, 94C for two
minutes to inactivate the AMV-RT enzyme and to dena-tides 5-CGGGGACCGGGTCCAGAGGGGCAGTG
CTGG-3 and 5-CCAGCACTGCCCCTCTGGACCCG ture the cDNA, 25 cycles of 94C for 30 seconds, 55C
for 30 seconds, 72C for 30 seconds, then a hold at 72CGTCCCCG-3were annealed to form the putative EGFR
VDRE. Another pair of synthetic oligonucleotides, for seven minutes to increase the yield of full length
product, and a hold at 4C. Ten microliters from each5-T TGGT GACTCAC CGGGTGAACGGGGGC
ATT-3 and 5-AATGCCCCCGTTCACCCGGTGAG tube was run on a 2% agarose gel in 1 TBE containing
0.5 g/mL ethidium bromide at 100V. Bands were quan-TCACCAA-3, was annealed to form the human osteo-
calcin VDRE. The double stranded oligomers were end- tified using 1D Image Analysis System (Kodak Digital
Science, Rochester, NY, USA).labeled with the Klenow enzyme and [-32P]dCTP (300
Ci/mmol). The labeled DNA probe was purified on a
Analysis of EGFR mRNA by quantitative RT-PCRSephadex G-50 column. Binding reactions contained 10
mmol/L Tris-HCl (pH 7.5), 1 mmol/L dithiothreitol (DTT), The procedure for quantitative RT-PCR was modified
from Bor et al [14] The methodology involves the use of100 mmol/L KCl, 15% glycerol, 50 g/mL polydeoxy-
nosinic-dexycytidylic acid and 2 g bovine serum albu- an internal standard and calibrators to generate a calibra-
tion curve. The level of EGFR-mRNA in the samples ismin (BSA). The proteins (hVDR and RXRwere kindly
provided by Dr. Paul MacDonald, Case Western Re- determined from the calibration curve as described be-
low. The internal standard was constructed using a com-serve University, Cleveland, OH, USA) were pre-incu-
bated with the binding reactions for 20 minutes at room mercially available Competitive DNA Construction Kit/
Competitive RNA Transcription Kit (Panvera; Takaratemperature. Fifty thousand to 100,000 dpm of DNA
probe was added to the reaction followed by a 30-minute Biomedicals, Madison, WI, USA). Briefly, a spacer DNA
consisting of a 0.3-kb fragment (residues 29750-30050) ofincubation at room temperature. The binding reactions
were then fractionated through a 4% polyacrylamide gel DNA (included in the Competitive DNA Construction
Kit) was amplified using synthetic oligonucleotide prim-(acrylamide:bisacrylamide, 80:1) in 23 mmol/L Tris bo-
rate, 0.5 mmol/L ethylenediaminetetraacetic acid (EDTA; ers P1 and P2 (Integrated DNA Technologies, Coralville,
IA, USA). The sequence of P1 was 5-ATTTAGGTGAC0.25  TBE) at 10 mA/gel. The gels were dried and then
exposed to film at 80C. ACTATAGAATACGAGAGGAGAACTGCCAGAA
GTACGGTCATCATCTGACAC-3 and contained the
Analysis of EGFR mRNA by RT-PCR SP6 polymerase promoter sequence (italics), the EGFR
gene specific forward primer (bold) and a region hy-Total RNA was isolated from cultures of UMR 106-01
cells using TRIzol Reagent (Gibco, Grand Island, NY, bridizing to the spacer DNA (underlined). The nucleo-
tide sequence of P2 was 5-TTTTTTTTTTTTTTTTTTTTUSA) according to the instructions provided by the man-
ufacturer and dissolved in 100 L nuclease free water. GTAGCATTTATGGAGAGTGCGCCATCCTGGGA
AGAC TCC-3 and contained a poly(dT) tail (italics), theThe RNA solution was transferred to a 0.2 mL polymer-
ase chain reaction (PCR) tube for DNase treatment with EGFR gene specific reverse primer (bold) and a region
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hybridizing to the spacer DNA (underlined). The PCR Preparation of stably transfected cells
reaction was performed using the reagents and instruc- UMR 106-01 osteoblast-like cells were plated 24 hours
tions provided by the manufacturer. Briefly, 10 pmol of prior to transfection in 60  15 mm dishes. Transfection
each primer was mixed with the Premix Solution con- was carried out using Effectine (Qiagen, Valencia, CA,
taining Taq polymerase, dNTPs and template (spacer) USA, USA) according to the manufacturer’s instruc-
DNA in a final volume of 50 L. The reactions were sub- tions. Cells were transfected with a 1 g of plasmid DNA
mitted to 30 rounds of amplification (denaturation 30 consisting of a luciferase reporter construct containing
seconds at 94C, annealing 30 seconds at 60C and exten- the full-length human EGFR promoter (Epro-Luc; a gift
sion 30 seconds at 72C). Amplification was confirmed from Dr. John D. Haley, Uniondale, NY, USA) or the
by demonstrating a band of the correct size by gel electro- vector alone (pUV102) and 10 g of pSV2-Neo vector,
phoresis, and the concentration of the product was quan- which confers G418 resistance. After allowing the cells
titated by absorbance at 260 nm. Five hundred nano- to express for 48 to 72 hours at 37C in a CO2 incubator,
grams of the product was used to prepare the RNA the transfected cells were passed into two new 60  10
internal standard by reverse transcription using SP6 mm dishes with 4 mL of growth medium containing 250
RNA Polymerase (1 L of 30 U/L) in the presence of g/mL of G418 (Geneticin; Gibco-BRL). The medium
40 mmol/L Tris-HCl (pH 5), 6 mmol/L MgCl2, 2 mmol/L was changed every other day. Colonies of resistant cells
Spermidine, 30 mmol/L DTT, 0.5 mmol/L of rNTPs (0.5 were observed after 10 to 14 days. Independent clones
mmol/L each) and 0.5 L RNase inhibitor (40 U/L). were selected using cloning discs (Fisher Scientific, Pitts-
The reaction was incubated at 37C for one hour, 1 L burgh, PA, USA) pre-wet in trypsin solution and subse-
of DNase (10 U/L) was added, and the incubation was quently passed into a new 24 well plate with 0.5 mL of
continued for an additional hour. Five microliters of 5 medium containing 125 g/mL of G418 in each well.
mol/L ammonium acetate and 165 L of 100% ethanol Cells were allowed to grow for three to five days before
were added, the solution was incubated at room tempera- passing into a 25 cm2 flask and were subsequently pas-
ture for five minutes followed by centrifugation at saged several times prior to use in the experiments. Con-
12,000  g for 15 minutes. After removing the superna- fluent cultures were exposed to the different test agents
tant, the pellet was washed with chilled 75% ethanol and for the times indicated. Cell extracts were prepared using
dried under a vacuum. The pellet was resuspended in a commercially available Reporter Lysis Buffer (Promega),
50 L of RNase-free water. The RNA internal standard followed by centrifugation. Luciferase enzyme activity was
was quantitated by absorbance at 260 nm. Quantitative assayed by adding Luciferase Assay Reagent (Promega)
RT-PCR was performed by coamplifying a fixed amount and the quantitation was performed using a luminometer.
of the RNA internal standard (0.564 pg) with six calibra-
Calculationstors and the unknown samples (UMR 106-01 RNA) be-
fore RT-PCR. The procedure for RT-PCR was as de- Statistical analyses were performed using the Student
scribed above. The calibrators were prepared from t test. Differences between groups were considered sig-
untreated UMR 106-01 total RNA (isolated as described nificant when P 	 0.05. Data are expressed as mean 

above) and contained 0.025, 0.05, 0.075, 0.1, 0.25 and 0.5 standard error of the mean.
g total RNA. A calibration curve was developed by
plotting the ratio between the amount of PCR product
RESULTSderived from the calibrators and the RNA internal stan-
Effect of calcitriol on EGFR mRNA levelsdard versus the amount of RNA present in the calibrator.
The amount of EGFR-mRNA in the samples was ob- To evaluate the effect of calcitriol on EGFR mRNA,
tained from the calibration curve based on the ratio we used a recently described method for mRNA quanti-
between the sample and the RNA internal standard. tation [14]. Figure 1A shows the levels of EGFR mRNA
in UMR 106-01 cells exposed to increasing concentra-
EGFR mRNA stability studies tions of calcitriol. Confluent cultures were treated for 48
Confluent cultures of UMR 106-01 cells were exposed hours with concentrations of calcitriol ranging from 1 to
to calcitriol (10 nmol/L) for 48 hours prior to the addi- 100 nmol/L. Exposure to calcitriol increased the level of
tion of 65mol/L 5,6-dichloro-1--d-ribofuranosyl benz- EGFR mRNA in a dose dependent manner with levels
imidazole (DRB). A set of untreated cultures also was that reached a threefold increase over control values at
exposed to DRB to use as controls. Total RNA from 100 nmol/L calcitriol. The time course for the effect of
transcriptionally arrested cells was isolated at different calcitriol to increase EGFR mRNA is shown in Fig-
time points for the following 12 hours using TRIzol Re- ure 1B. Confluent cultures were treated with 10 nmol/L
agent (Gibco). The levels of EGFR mRNA were deter- calcitriol for different time periods. There was a progres-
sive increase in the level of EGFR mRNA levels withmined by RT-PCR as described above.
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As shown in Figure 2, recombinant human VDR binds to
the oligonucleotide containing the putative EGFR VDRE
in an RXR-dependent manner (Fig. 2, lane 3). Similar
results were obtained using an oligonucleotide contain-
ing the human osteocalcin VDRE (Fig. 2, lane 7). This
finding suggested that the effect of calcitriol to increase
EGFR mRNA might be transcriptionally mediated.
Effect of calcitriol on EGFR gene transcription
To assess the effect of calcitriol on transcriptional ac-
tivity of the EGFR gene promoter, cultures of UMR
106-01 cells that had been stably transfected with a lucif-
erase reporter plasmid driven by the full-length EGFR
gene promoter were exposed to calcitriol for up to 24
hours. As shown in Figure 3, there was no increase in lu-
ciferase activity as compared to control cultures. A lack
of effect of calcitriol on EGFR gene transcriptional activ-
ity was also noted using transient transfections of UMR
106-01 cells as well as COS-7 cells (data not shown). Thus,
the interaction of the VDR with the putative EGFR
VDRE demonstrated by EMSA did not appear to be
functionally relevant in the sense that we could not dem-
onstrate an increase in transcriptional activity in re-
sponse to calcitriol. These observations indicated that
the mechanism for the increase in EGFR mRNA in re-
sponse to calcitriol was not explained by increased gene
transcription, and suggested that calcitriol might be af-
fecting the stability of the EGFR mRNA.
Fig. 1. Effect of calcitriol on epidermal growth factor receptor (EGFR)
mRNA levels. (A) Confluent cultures of UMR 106-01 cells were exposed Effect of calcitriol on EGFR mRNA stabilityto calcitriol for 48 hours at the doses indicated. (B) Cultures were
exposed to calcitriol (10 nmol/L) for the time periods indicated (each To determine whether the increase in EGFR mRNA
set of experiments was terminated simultaneously following timed pre- levels in response to calcitriol was due to changes intreatments). Untreated cultures served as controls. Total RNA was
EGFR mRNA stability, we assessed the rate of degrada-isolated and EGFR-mRNA levels were determined using quantitative
RT-PCR as described under materials and methods. The values repre- tion of the EGFR mRNA in control cultures and in
sent the mean 
 SEM for three separate experiments. * Significantly cultures exposed to calcitriol. Cells were transcription-different from control.
ally arrested by inhibiting RNA polymerase II with DRB
and total RNA was subsequently isolated at various
times. As shown in Figure 4 the EGFR mRNA from
increased exposure time with values reaching a 2.5-fold control cultures was degraded approximately six times
increase over control values after 72 hours of treatment. faster than of cells that had been exposed to calcitriol,
suggesting that calcitriol increases EGFR expression by
Determination of a potential VDRE in the EGFR affecting the stability of EGFR mRNA.
gene promoter
Effect of PTH on EGFR gene transcriptionIn order to determine if the mechanism of the effect
of calcitriol to increase EGFR mRNA levels involved We had previously demonstrated that PTH also in-
increased transcription of the EGFR gene, we first exam- creased EGFR mRNA levels in UMR 106-01 cells. Our
ined the EGFR gene promoter for potential VDRE con- present studies examined the effect of PTH on EGFR
sensus sequences. A region at position 539 (GGGTCC gene transcription. UMR 106-01 cells were stably trans-
AGA GGGGCA) was identified as a potential VDRE fected with a luciferase reporter plasmid driven by the
on the basis of its homology with the human osteocal- full length EGFR gene promoter and luciferase activity
cin VDRE (GGGTGA ACG GGGGCA). Synthetic oli- was measured four hours after exposure to PTH (10
gonucleotides containing the putative human EGFR nmol/L). As shown in Figure 3, luciferase activity was
VDRE were annealed, radiolabeled, and tested for bind- ninefold higher in cells exposed to PTH as compared
ing to recombinant human VDR. Binding of the VDR to control cultures. The effect of PTH on EGFR-gene
transcription was dose dependent (Fig. 5A). Luciferaseto the putative EGFR VDRE was examined by EMSA.
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Fig. 2. Electromobility shift assay (EMSA)
using the human osteocalcin vitamin D re-
sponse element (VDRE), and the putative hu-
man EGFR VDRE as probes. In lanes 1 and
5, the binding reaction was carried out in the
presence of recombinant vitamin D receptor
(VDR); in lanes 2 and 6, the binding reaction
was carried out in the presence of recombinant
RXR. Lanes 3 and 7 illustrate the protein
DNA complexes when both VDR and RXR
are included in the binding reactions. In lanes
4 and 8, the conditions are the same as in lanes
3 and 7 except that excess unlabeled probe
was added to the reactions.
activity increased progressively at concentrations rang- expression in UMR 106-01 cells in response to PTH was
mediated by the adenylate cyclase/cAMP pathway [11].ing from 0.1 nmol/L to 10 nmol/L. The ninefold increase
in EGFR gene transcription noted with 10 nmol/L PTH
remained unchanged when cells were exposed to 100 DISCUSSION
nmol/L PTH. The time course for the effect of PTH on
Calcitriol and PTH are important calciotropic hor-EGFR gene transcription is shown in Figure 5B. Two
mones that have a variety of direct and indirect effects on
hours after exposure to 10 nM PTH, luciferase activity
bone cells. The effects of PTH on target tissues are medi-
demonstrated a twofold increase from control values; an ated by the PTH/PTHrP receptor, a G-protein coupled
additional fivefold increase was noted after three hours receptor that signals via adenylate cyclase as well as phos-
and transcriptional activity reached a plateau between pholipase C [15]. Calcitriol exerts its effects by binding
three and four hours of exposure to PTH. Treatment of to the vitamin D receptor (VDR), which in turn forms
the cells with forskolin had a similar effect on luciferase a heterodimer with the retinoid X receptor (RXR) and
activity as that noted with PTH, whereas no increase in interacts with the vitamin D responsive element (VDRE)
luciferase activity was noted in response to PMA (Fig. 6). in target genes [16, 17]. In addition to these two well-
Similarly, in experiments using transient transfections, known hormones, a variety of growth factors and cyto-
treatment with PTH as well as forskolin resulted in in- kines have been shown to be involved in bone metabo-
creased luciferase activity whereas PMA had no effect lism [18–21]. One of these factors, EGF, is a potent
(data not shown). These data support our previous find- mitogen that has been shown to play a role in the prolifer-
ation of many cell types including osteoblasts. The ac-ings demonstrating that the increase in EGF receptor
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Fig. 4. Effect of calcitriol on EGFR mRNA stability. UMR 106-01
cells were exposed to calcitriol (10 nmol/L; ) for 48 hours before the
addition of DRB (65 mol/L). Untreated cultures served as controls
(). Total RNA was isolated at the indicated times following the addi-
tion of DRB. The levels of EGFR mRNA were determined by RT-PCR.
Values represent the mean 
 SEM for 3 separate experiments.
tors. Using a bone derived cell line, RCJ 1.20, Petkovich
et al demonstrated a two- to threefold increase in EGFR
number after exposure to calcitriol that was associated
with an increase in EGF-dependent growth [22]. In hu-
man breast cancer cells (BT-20), Falette et al found in-
creased EGF binding in response to calcitriol [22], and
Fig. 3. Effect of calcitriol and parathyroid hormone (PTH) on EGFR Desperez and coworkers demonstrated that calcitriol in-
gene transcription. UMR 106-01 cells were stably transfected with a creased the levels of EGFR mRNA [23]. Using the same
luciferase reporter plasmid driven by the full-length human EGFR gene
cell line, however, Koga, Eisman and Sutherland foundpromoter. Cells were exposed to PTH (10 nmol/L) or calcitriol (100
nmol/L) for 4 hours. Untreated transfectants were used as controls. no effect of calcitriol on EGF binding [24]. The discrep-
Values represent the mean 
 SEM for 4 separate experiments per- ancy between these findings may have been related to
formed in duplicate. * Significantly different from control.
the short duration of exposure to calcitriol in the latter
studies. Calcitriol also has been found to decrease EGFR
binding in other cell lines [24, 25], which may be related
to cell specific differences. The above studies did not ad-tions of EGF are mediated by the EGFR, a transmem-
brane glycoprotein with intrinsic tyrosine kinase activity. dress the mechanism of the effect of calcitriol on EGFR
binding. We find that although in vitro the VDR interactsWe have previously demonstrated that both calcitriol
and PTH increase EGFR binding in UMR-106-01 cells, with a region of the EGFR promoter, there was no effect
on transcription in response to calcitriol in UMR 106-01and that the effect of PTH to increase EGF receptors
was mediated by cAMP and was due to increased levels cells transfected with a luciferase reporter construct driven
by the full length EGFR promoter. Instead, our findingsof EGFR mRNA [11, 12]. The present studies demon-
strate that calcitriol also increased EGFR mRNA and suggest that the effect of calcitriol is mediated by stabili-
zation of EGFR mRNA. Regulation of EGFR expres-that the regulation of EGFR expression in UMR-106-01
cells by calcitriol and PTH occurs via different mecha- sion at the level of mRNA decay has been demonstrated
in a variety of cancer cell lines [26–28] and more recently,nisms. PTH increased EGFR gene transcription in a
time- and dose-dependent manner, and the effect of PTH Balmer et al identified an AU-rich element in the 3
untranslated region of the EGFR gene that is a targetwas mimicked by forskolin thus implicating the adenyl-
ate cyclase pathway in this aspect of PTH action. Calcit- for multiple regulated RNA-binding proteins [26].
The regulation of EGFR expression by PTH via ariol, on the other hand, did not have an effect on EGFR
gene transcription, but instead it increased the stability cAMP dependent mechanism that we have described in
previous studies is consistent with the observations byof the EGFR mRNA.
Our finding of increased EGFR expression in response Ohta and colleagues using MC3T3-E1 cells [29]. The au-
thors reported a decrease in EGFR binding in responseto calcitriol is consistent with studies by other investiga-
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Fig. 5. Time- and dose-dependent effect of PTH on EGFR gene tran-
Fig. 6. Effect of mediators of PTH action on EGFR gene transcription.scription. UMR 106-01 cells were stably transfected with a luciferase
UMR 106-01 cells were stably transfected with a luciferase reporter plas-reporter plasmid driven by the full-length human EGFR gene promoter.
mid driven by the full-length human EGFR gene promoter. Cells were(A) Cells were exposed to PTH for 4 hours at the concentrations indicated.
exposed to the test agents indicated for 4 hours. Untreated transfectants(B) Cells were exposed to 10 nmol/L PTH for the time periods indicated.
were used as controls. Values represent the mean 
 SEM for 4 sepa-Cell lysates were prepared simultaneously following the timed pre-
rate experiments performed in duplicate. * Significantly different fromtreatments and luciferase activity was measured using a luminometer.
control.Untreated transfectants served as controls. Each experiment was done
in duplicate. Values represent the mean 
 SEM for 3 separate experi-
ments performed in duplicate. * Significantly different from control.
tion. Although the exact role of EGF in bone remains
unclear, the fact that its expression is regulated by the
to PTH that was mimicked by forskolin and cAMP ana- major calciotropic hormones suggests that it may be im-
logs. The differences in the direction of the effect of portant in the local regulation of bone remodeling. Fur-
PTH on EGFR binding as compared to our studies in ther studies on the effects of EGF on bone cells and the
UMR 106-01 cells may be related to cell-specific differ- mechanisms involved in the regulation of EGF actions
ences. Our finding of increased EGFR binding in re- will provide insight into the role of this growth factor in
sponse to PTH are in agreement with the studies of the integrated biology of the skeleton.
Alsat et al demonstrating increased EGFR receptors in
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